Clinical Trials Browser

OTHER_GOV × Paclitaxel × Gastrointestinal × Clear all

NCT06793917 2025-07-20

Tislelizumab Plus FOLFOX Versus POF in the Treatment of Locally Advanced: a Multicenter, Open-label, Randomized Phase III Studyunresectable or Metastatic Gastric/Gastroesophageal Junction Adenocarcinoma

Phase 3 Recruiting

Gastrointestinal

Stomach Neoplasms

NCT05319639 2025-02-27

Phase I/II Study of the Combination of Irinotecan and POF (POFI) and Tislelizumab

Phase 1/2 Recruiting

Gastrointestinal

Stomach Neoplasms

NCT05628610 2024-08-13

Tislelizumab Combined With Chemotherapy or Radiotherapy in the Treatment of Advanced or Recurrent Metastatic Elderly Esophageal Cancer

Phase 2 Not yet recruiting

Gastrointestinal

Esophageal Neoplasms

NCT06197438 2024-01-09

Phase II Study of the Combination of Irinotecan and POF (POFI) and Tislelizumab in Advanced Gastric Cancer

Phase 2 Unknown

Gastrointestinal

Stomach Neoplasms

NCT05751265 2023-06-22

Tislelizumab Combined With Chemotherapy in the Cross-line Treatment of First-line Resistant Advanced Gastric Cancer

Phase 2 Unknown

Gastrointestinal

Stomach Neoplasms

NCT05569668 2022-10-06

Neoadjuvant Chemotherapy Compared With Surgery for Esophageal Carcinoma

Gastrointestinal

Esophageal Neoplasms

NCT04063683 2021-08-24

Paclitaxel and DDP Combined With Anlotinib in the First-line Treatment for Patients With Advanced Esophageal Squamous Cell Carcinoma（ESCC）.

Phase 2 Unknown

Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT05013697 2021-08-19

TQB2450 Solution for Injection (TQB2450)+Paclitaxel+Cisplatin ± Anlotinib in the Treatment of Esophageal Cancer.

Phase 2 Unknown

Gastrointestinal

Esophageal Neoplasms

NCT02741856 2018-10-25

SCOPE2

Phase 2/3 Unknown

Gastrointestinal

Esophageal Neoplasms

NCT02924909 2018-03-20

QUIMERA

Phase 2 Unknown

Gastrointestinal

Esophageal Neoplasms

NCT01843829 2014-03-24

NeoSCOPE

Phase 2 Unknown

Gastrointestinal

Esophageal Neoplasms

NCT00453323 2010-07-12

Paclitaxel and Capecitabine in Patients With Metastatic/Recurrence Esophageal Cancer

Phase 2 Unknown

Gastrointestinal

Esophageal Neoplasms